Fredun Pharma Board Approves Un-Audited Financial Results

Fredun Pharmaceuticals Ltd announced that its Board of Directors, in a meeting held on August 5, 2026, has approved the un-audited financial results for the quarter ended June 30, 2026. The results were accompanied by a limited review report from the statutory auditors, M/s. R.H. Nisar & Co. The trading window for company insiders was closed from July 1, 2026, until 48 hours after the declaration of the board meeting's outcome. The board meeting commenced at 10:30 a.m. and concluded at 11:20 a.m.